By Dr Tayla Degan

Preprints

Reilly R; McKetin R; Barzi F; Degan T; Ezard N; Conigrave K; Butt J; Roe Y; Wand H; Quinn B; Longbottom W; Treloar C; Dunlop A; Ward J, 2024, We Can Do This: A web-based therapeutic program for reducing methamphetamine use -amongst Aboriginal and Torres Strait Islander people: Findings from a wait-list control, randomised trial (Preprint), http://dx.doi.org/10.2196/preprints.58341

McKetin R; Degan T; Saunders L; Nguyen L; Dore G; Shoptaw S; Farrell M; Degenhardt L; Kelly P; Turner A; Clare P; Dean O; Arunogiri S; Colledge-Frisby S; Koeijers J; Goodman-Meza D; Sinclair B; Reid D; Hill H; Hayllar J; Christmass M; Cordaro F; Lundin R; Liaw W; Liu D; Holyoak E; Wu BT-F; Kegan J; Kontogiannis A; Palmer L; Morrison C; Wrobel A; Hyland R; Byrne M; Zahra E; Russell S; Berk M, 2024, A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: A study protocol for the Tina Trial, http://dx.doi.org/10.21203/rs.3.rs-3984655/v1

Davis EL; Kelly P; Deane F; Buckingham M; Breeze D; Degan T, 2020, A qualitative study exploring the benefits and challenges of implementing client centered care in a substance dependence rehabilitation service, http://dx.doi.org/10.21203/rs.3.rs-24274/v1

Back to profile page